These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29473730)

  • 1. Noncatalytic Endosialidase Enables Surface Capture of Small-Cell Lung Cancer Cells Utilizing Strong Dendrimer-Mediated Enzyme-Glycoprotein Interactions.
    Hsu HJ; Palka-Hamblin H; Bhide GP; Myung JH; Cheong M; Colley KJ; Hong S
    Anal Chem; 2018 Mar; 90(6):3670-3675. PubMed ID: 29473730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system.
    Hosokawa M; Kenmotsu H; Koh Y; Yoshino T; Yoshikawa T; Naito T; Takahashi T; Murakami H; Nakamura Y; Tsuya A; Shukuya T; Ono A; Akamatsu H; Watanabe R; Ono S; Mori K; Kanbara H; Yamaguchi K; Tanaka T; Matsunaga T; Yamamoto N
    PLoS One; 2013; 8(6):e67466. PubMed ID: 23840710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy.
    Shen J; Zhao J; Jiang T; Li X; Zhao C; Su C; Zhou C
    Oncotarget; 2017 Jul; 8(30):49044-49052. PubMed ID: 28467771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer.
    Beck TN; Boumber YA; Aggarwal C; Pei J; Thrash-Bingham C; Fittipaldi P; Vlasenkova R; Rao C; Borghaei H; Cristofanilli M; Mehra R; Serebriiskii I; Alpaugh RK
    BMC Cancer; 2019 Jun; 19(1):603. PubMed ID: 31215484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective capture of circulating tumor cells from a transgenic mouse lung cancer model using dendrimer surfaces immobilized with anti-EGFR.
    Myung JH; Roengvoraphoj M; Tam KA; Ma T; Memoli VA; Dmitrovsky E; Freemantle SJ; Hong S
    Anal Chem; 2015 Oct; 87(19):10096-102. PubMed ID: 26312815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EpCAM-independent capture of circulating tumor cells with a 'universal CTC-chip'.
    Chikaishi Y; Yoneda K; Ohnaga T; Tanaka F
    Oncol Rep; 2017 Jan; 37(1):77-82. PubMed ID: 27840987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small cell lung cancer: Circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype.
    Hamilton G; Hochmair M; Rath B; Klameth L; Zeillinger R
    Cell Adh Migr; 2016 Jul; 10(4):360-7. PubMed ID: 26919626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined use of EpCAM and FRα enables the high-efficiency capture of circulating tumor cells in non-small cell lung cancer.
    Chen L; Peng M; Li N; Song Q; Yao Y; Xu B; Liu H; Ruan P
    Sci Rep; 2018 Jan; 8(1):1188. PubMed ID: 29352248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of a novel microfluidic device for epitope-independent enrichment of circulating tumour cells in patients with small cell lung cancer.
    Chudziak J; Burt DJ; Mohan S; Rothwell DG; Mesquita B; Antonello J; Dalby S; Ayub M; Priest L; Carter L; Krebs MG; Blackhall F; Dive C; Brady G
    Analyst; 2016 Jan; 141(2):669-78. PubMed ID: 26605519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NCAM polysialylation during adherence transitions: live cell monitoring using an antibody-mimetic EGFP-endosialidase and the viability dye DRAQ7.
    Smith PJ; Furon E; Wiltshire M; Chappell S; Patterson LH; Shnyder SD; Falconer RA; Errington RJ
    Cytometry A; 2013 Jul; 83(7):659-71. PubMed ID: 23716295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface engineering for efficient capture of circulating tumor cells in renal cell carcinoma: From nanoscale analysis to clinical application.
    Bu J; Nair A; Kubiatowicz LJ; Poellmann MJ; Jeong WJ; Reyes-Martinez M; Armstrong AJ; George DJ; Wang AZ; Zhang T; Hong S
    Biosens Bioelectron; 2020 Aug; 162():112250. PubMed ID: 32392161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendrimer-Based Platform for Effective Capture of Tumor Cells after TGFβ
    Myung JH; Cha A; Tam KA; Poellmann M; Borgeat A; Sharifi R; Molokie RE; Votta-Velis G; Hong S
    Anal Chem; 2019 Jul; 91(13):8374-8382. PubMed ID: 31247718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Characterization of Circulating Tumor Cells Enriched by A Microfluidic Platform in Patients with Small-Cell Lung Cancer.
    Obermayr E; Agreiter C; Schuster E; Fabikan H; Weinlinger C; Baluchova K; Hamilton G; Hochmair M; Zeillinger R
    Cells; 2019 Aug; 8(8):. PubMed ID: 31412616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of salinomycin and niclosamide on small cell lung cancer and small cell lung cancer circulating tumor cell lines.
    Hochmair M; Rath B; Klameth L; Ulsperger E; Weinlinger C; Fazekas A; Plangger A; Zeillinger R; Hamilton G
    Invest New Drugs; 2020 Aug; 38(4):946-955. PubMed ID: 31446534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer.
    Hamilton G; Rath B
    Adv Exp Med Biol; 2017; 994():229-245. PubMed ID: 28560677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor cells: clinically relevant molecular access based on a novel CTC flow cell.
    Winer-Jones JP; Vahidi B; Arquilevich N; Fang C; Ferguson S; Harkins D; Hill C; Klem E; Pagano PC; Peasley C; Romero J; Shartle R; Vasko RC; Strauss WM; Dempsey PW
    PLoS One; 2014; 9(1):e86717. PubMed ID: 24489774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved detection by ensemble-decision aliquot ranking of circulating tumor cells with low numbers of a targeted surface antigen.
    Johnson ES; Anand RK; Chiu DT
    Anal Chem; 2015 Sep; 87(18):9389-95. PubMed ID: 26302174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancer.
    Normanno N; Rossi A; Morabito A; Signoriello S; Bevilacqua S; Di Maio M; Costanzo R; De Luca A; Montanino A; Gridelli C; Rocco G; Perrone F; Gallo C
    Lung Cancer; 2014 Aug; 85(2):314-9. PubMed ID: 24882383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of circulating tumor cells detected with the microfluidic "universal CTC-chip" for primary lung cancer.
    Kanayama M; Kuwata T; Mori M; Nemoto Y; Nishizawa N; Oyama R; Matsumiya H; Taira A; Shinohara S; Takenaka M; Yoneda K; Kuroda K; Ohnaga T; Tanaka F
    Cancer Sci; 2022 Mar; 113(3):1028-1037. PubMed ID: 34964211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence.
    Garcia J; Barthelemy D; Geiguer F; Ballandier J; Li KW; Aurel JP; Le Breton F; Rodriguez-Lafrasse C; Manship B; Couraud S; Payen L
    J Vis Exp; 2019 Aug; (150):. PubMed ID: 31475991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.